Study on the efficacy of nettle in the treatment of type 2 diabetic patients
Phase 3
- Conditions
- Type 2 diabetes mellitus.Non-insulin-dependent diabetes mellitus (type 2)
- Registration Number
- IRCT138809022288N2
- Lead Sponsor
- Institute of Medicinal Plants affiliated with ACECR
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
type 2 diabetic patients, patients aged 40 to 60 years, patients with fasting serum glucose level above 200 mg/dl, patients with blood glycosylated hemoglobin level above 8 percent, patients who despite using a combination of oral synthetic antidiabetic drugs, their blood glucose level is not within the normal range and thus need insulin injection but refuse to inject insulin. Exclusion criteria:patients with cardiac, renal, hepatic diseases, concomitant infections, pregnant women, women planning pregnancy, breast-feeding women.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Decrease of the serum glucose level. Timepoint: 3 months. Method of measurement: Medical laboratory (kit).;Decrease of the blood glycosylated hemoglobin level. Timepoint: 3 months. Method of measurement: Medical laboratory (kit).
- Secondary Outcome Measures
Name Time Method Increase of the serum creatinin level. Timepoint: 3 months. Method of measurement: Medical laboratory (kit).;Increase of the serum level of the liver enzyme SGOT. Timepoint: 3 months. Method of measurement: Medical laboratory (kit).;Increase of the srum level of the liver enzyme SGPT. Timepoint: 3 months. Method of measurement: Medical laboratory (kit).